COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation (NCT05076266) | Clinical Trial Compass
TerminatedNot Applicable
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Stopped: slower than expected accrual.
United States14 participantsStarted 2022-03-14
Plain-language summary
The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.
Who can participate
Age range
45 Years – 75 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Participants must be women age 45 or older and under age 75 at the time of study entry.
Participant must be scheduled for, or have intent to schedule, a screening mammogram.
Participant must be eligible for EA1151/TMIST. Participant must have declined participation in EA1151/TMIST. Participant must be able to complete questionnaires in English. Participant must have a U.S. zip code.
Exclusion Criteria:
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1I saw that this study was terminated before it completed — do you know why it was stopped, and does that affect whether the research findings are still useful for understanding financial hardship related to breast cancer screening?
2This study was specifically looking at how COVID-related financial hardship affects women's decisions about participating in breast cancer screening trials — is financial stress or cost something that should factor into our conversation about my own screening or treatment options?
3Since this trial focused on women of color and potential differences in financial barriers to trial participation, are there support resources or financial assistance programs you'd recommend I look into if cost is a concern for me?
4This study was examining women who declined a separate breast cancer screening trial called TMIST — is TMIST or a similar screening study something that might be worth considering in my situation, and what would that involve?
5Since this research is observational and focused on financial and emotional distress rather than a treatment, what does it tell us about the real-world barriers patients face, and how does that affect the options you'd recommend I consider?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Compare the Proportion of Women of Color (WOC) Participants Who Experience the Composite Outcome of COVID-related Financial Hardship vs Non-WOC Participants